Status:
COMPLETED
Essential Fatty Acids During Complementary Feeding
Lead Sponsor:
University of Copenhagen
Collaborating Sponsors:
Axellus
Conditions:
Obesity
Growth
Eligibility:
All Genders
8-19 years
Phase:
NA
Brief Summary
The objective of this intervention study is to examine the effect of n-3 LCPUFA on growth and body composition, intestinal health and microbiotic composition, immune function and risk markers for late...
Eligibility Criteria
Inclusion
- Singleton infants, 9 mo +/- 2 wk, born \>= 37 wk of gestation
- Birth weight \>=2500g, a 5-min Apgar score \>= 7, birth weight \>= 5th percentile for gestational age
Exclusion
- Chronic diseases expected to influence growth and dietary intake
- Use of medicine expected to influence growth and dietary intake
- Fish oil supplementation
Key Trial Info
Start Date :
February 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2009
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00631046
Start Date
February 1 2008
End Date
May 1 2009
Last Update
July 15 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. of Human Nutrition
Copenhagen, Frederiksberg C, Denmark, DK-1958